英文稿 | 中央社訊息平台

歡迎公司行號投遞新聞訊息（如文字、照片或活動預告等），詳洽業務行銷中心：
電話：886-2-2505-1180 轉781~786 或 790~797 傳真：886-2-2502-3805

No	Time	標題
21	2019-09-23　09:31:00	Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases
20	2019-09-20　15:58:00	JT is included in DJSI Asia Pacific for the sixth consecutive year
19	2019-09-20　09:35:00	Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors
18	2019-09-20　09:34:00	Edwards’ 100th Year Environmental Award Recognises SEMI High-Tech Facility Committee
17	2019-09-20　09:33:00	Amazon Co-founds The Climate Pledge, Setting Goal to Meet the Paris Agreement 10 Years Early
16	2019-09-11　10:02:00	Samsung Bioepis Continues Global Expansion, Enters Brazilian Biopharmaceutical Market with BRENZYS™ (etanercept)
15	2019-09-10　09:34:00	Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
14	2019-09-09　17:52:00	SES Selects SpaceX to Launch Groundbreaking O3b mPOWER MEO Communications System
13	2019-09-09　15:43:00	SES Extends Global Reach of Microsoft Azure ExpressRoute with Multi-orbit Satellite Systems
12	2019-09-09　15:42:00	SES to Deliver Premium Broadcast-Grade Cloud Service for Media Delivery on Microsoft Azure
11	2019-09-09　15:39:00	SES to Deliver Cloud-enabled Solutions
10	2019-09-04　16:11:22	Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound
9	2019-09-04　16:10:58	Results from RE-SPECT CVT® published - first trial of NOAC in cerebral venous thrombosis
8	2019-09-04　09:35:16	GN Hearing Becomes World’s First to Support Direct Android Streaming to Hearing Devices Using Bluetooth Low Energy
7	2019-09-04　09:34:40	Xiang He Capital closes second US dollar venture fund at $425 million
6	2019-09-03　14:32:00	Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes
5	2019-09-02　14:18:00	SES Announces Andrew Browne Will Step Down as CFO in October
4	2019-08-31　11:36:00	Taiwan’s VR films rank among the best in the world
3	2019-08-30　15:31:00	Anniversary of the pivotal RE-LY® trial marks a decade of innovation for stroke prevention in AF patients
2	2019-08-30　10:36:00	Panasonic Joins RE100 Aiming for Business Operations with 100% Renewable Energy
1	2019-08-30　09:28:00	Athena Home Loans Partners with Q2’s Cloud Lending to Provide Digital-First Mortgage Lending Experience


		新聞稿刊載服務請洽本社業務行銷中心人員，電話（02）2505-1180 轉 781 ~ 786 或 790 ~ 797 本平台資料均由投稿單位輸入後對外公布,資料如有錯誤、遺漏或虛偽不實,均由投稿單位負責